CFR Expert Discusses Success Of Experimental Ebola Vaccine In DRC

Council on Foreign Relations’ “Africa in Transition”: The Ebola Vaccine Is Highly Effective in Eastern Congo
John Campbell, Ralph Bunche senior fellow for Africa Policy Studies at CFR, discusses the success of an experimental Ebola vaccine developed by Merck & Co being used in the Democratic Republic of the Congo (DRC) outbreak. Campbell says the vaccine’s results are “unalloyed good news” (4/19).